Ramanjaneyulu Allam

7PUBLICATIONS
37CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Haematological tumoursImmunogenetics (incl. genetic immunology)Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 31, 2024
Ribonuclease inhibitor and angiogenin system regulates cell type-specific global translation.

Martina Stillinovic, Mayuresh Anant Sarangdhar, Nicola Andina

|Jan 20, 2023
Increased Inflammasome Activation Is Associated with Aging and Chronic Myelomonocytic Leukemia Disease Severity.

Nicola Andina, Louise de Meuron, Annatina Sarah Schnegg-Kaufmann

|Mar 08, 2022
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity.

Giuseppe Bombaci, Mayuresh Anant Sarangdhar, Nicola Andina

|Jul 02, 2021
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.

Ioannis Chanias, Kristina Stojkov, Gregor Th Stehle

|Feb 02, 2021
Angiogenin (ANG)-Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease.

Mayuresh Anant Sarangdhar, Ramanjaneyulu Allam

Pageof 2